Abstract
The treatment of autoimmune hepatitis is evolving as the natural history of the disease and newer agents become available. This concise review will outline the various treatment options in these patients. Treatment with current corticosteroids and azathioprine works in most patients but issues of intolerance and incomplete response arise. These situations led to the investigation of newer immunosupressants including mycophenolate mofetil, budesonide cyclosporine, tacrolimus and ursodeoxycholic acid. The newer agents have been studied in small patient numbers so they are not first-line treatment yet but do have a clear role in those patients with intolerance of incomplete response to standard corticosteroids and azathioprine.
Original language | English (US) |
---|---|
Pages (from-to) | 204-207 |
Number of pages | 4 |
Journal | Annals of Hepatology |
Volume | 6 |
Issue number | 4 |
DOIs | |
State | Published - 2007 |
Externally published | Yes |
Keywords
- Azathioprine
- Mycophenolate mofetil
- Remission
- Ursodeoxycholic acid
ASJC Scopus subject areas
- Hepatology